PCYC

Pharmacyclics, Inc. News Headlines

$168.75
*  
1.28
0.76%
Get PCYC Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading PCYC now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Pharmacyclics Up on Imbruvica Label Expansion in the U.S. - Analyst Blog
1/30/2015 5:55:00 PM - Zacks.com


Seeking Alpha's Biotech Weekly: Intercept Pops, Provenge's Prince Valeant, And More
1/30/2015 4:00:00 PM - Seeking Alpha


3 Biotechs Looking Good this Earnings Season - Earnings ESP
1/30/2015 12:38:10 PM - Zacks.com


Pharmacyclics : FDA Oks Imbruvica To Treat Waldenstrom's Macroglobulinemia
1/29/2015 7:54:00 PM - RTT News


5 Things Johnson & Johnson's Management Wants You to Know
1/26/2015 1:04:02 PM - Motley Fool


With The Fed Fading Into The Shadows, Investors Look Overseas For New Catalysts
1/26/2015 2:50:00 AM - Seeking Alpha


Why You Shouldn't Bet Against Pharmacyclics (PCYC) Stock - Tale of the Tape
1/23/2015 8:40:00 AM - Zacks.com


Pharmacyclics Has Moderate Upside And A Very Limited Downside
1/22/2015 12:12:00 PM - Seeking Alpha


Why Pharmacyclics (PCYC) Could Be Positioned for a Surge? - Tale of the Tape
1/20/2015 8:36:00 AM - Zacks.com


Can The Uptrend Continue for Pharmacyclics (PCYC)? - Tale of the Tape
1/16/2015 8:44:14 AM - Zacks.com


The Next Stock I Would Build A Retirement Portfolio Upon At Any Age
1/15/2015 4:07:00 PM - Seeking Alpha


Pharmacyclics Inc. (PCYC): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/15/2015 7:00:00 AM - Investopedia


Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
1/14/2015 2:39:00 PM - Investopedia


Biotech Stock Roundup: Shire to Acquire NPSP, Celgene & Pharmacyclics Give Strong Outlook - Analyst Blog
1/14/2015 2:39:00 PM - Zacks.com


Company News for January 14, 2015 - Corporate Summary
1/14/2015 10:10:00 AM - Zacks.com


Pharmacyclics (PCYC) Looks Good: Stock Moves 16.4% Up - Tale of the Tape
1/14/2015 8:51:00 AM - Zacks.com


Pharmacyclics Reports Preliminary Results and 2015 Outlook - Analyst Blog
1/13/2015 7:10:00 PM - Zacks.com


Tuesday's ETF with Unusual Volume: VLUE
1/13/2015 3:23:03 PM - BNK Invest


Tuesday's ETF Movers: FBT, GDX
1/13/2015 3:22:28 PM - BNK Invest


Health Care Sector Update for 01/13/2015: PCYC,STXS,ATRS
1/13/2015 1:38:08 PM - MT Newswires


Mid-Day Market Update: Pharmacyclics Surges On Strong Preliminary 2014 Results; Fresh Market Shares Slip
1/13/2015 1:24:49 PM - Benzinga


Why Pharmacyclics Inc. Skyrocketed Higher Today
1/13/2015 1:18:15 PM - Motley Fool


Stocks Remain Firmly Positive Following Early Rally - U.S. Commentary
1/13/2015 11:57:00 AM - RTT News


Mid-Morning Market Update: Markets Open Higher; Alcoa Profit Beats Expectations
1/13/2015 11:30:21 AM - Benzinga


Upbeat Earnings News Leads To Early Strength On Wall Street - U.S. Commentary
1/13/2015 10:18:00 AM - RTT News